These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23109704)

  • 61. Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.
    Muranen TA; Mavaddat N; Khan S; Fagerholm R; Pelttari L; Lee A; Aittomäki K; Blomqvist C; Easton DF; Nevanlinna H
    Breast Cancer Res Treat; 2016 Aug; 158(3):463-9. PubMed ID: 27438779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.
    Dorling L; Barnett GC; Michailidou K; Coles CE; Burnet NG; Yarnold J; Elliott RM; Dunning AM; Pharoah PD; West CM
    Clin Cancer Res; 2016 Mar; 22(6):1413-20. PubMed ID: 26510858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.
    Sapkota Y
    Cytogenet Genome Res; 2014; 144(2):77-91. PubMed ID: 25401968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk.
    Kaur R; Meiser B; Yanes T; Young MA; Barlow-Stewart K; Roscioli T; Smith S; James PA
    Fam Cancer; 2019 Apr; 18(2):147-152. PubMed ID: 30251170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer.
    Baliakas P; Munters AR; Kämpe A; Tesi B; Bondeson ML; Ladenvall C; Eriksson D
    J Med Genet; 2024 Jan; 61(2):150-154. PubMed ID: 37580114
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
    Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
    Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polygenic risk score (PRS) and its potential for breast cancer risk stratification.
    Hovhannisyan M; Kleiblová P; Nehasil P; Soukupová J; Zemánková P; Kleibl Z; Janatová M
    Klin Onkol; 2023; 36(3):198-205. PubMed ID: 37353348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genomic Biomarkers for Breast Cancer Risk.
    Walsh MF; Nathanson KL; Couch FJ; Offit K
    Adv Exp Med Biol; 2016; 882():1-32. PubMed ID: 26987529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients.
    Al-Jumaan M; Chu H; Alsulaiman A; Camp SY; Han S; Gillani R; Al Marzooq Y; Almulhim F; Vatte C; Al Nemer A; Almuhanna A; Van Allen EM; Al-Ali A; AlDubayan SH
    Genome Med; 2023 Sep; 15(1):65. PubMed ID: 37658461
    [TBL] [Abstract][Full Text] [Related]  

  • 71. c-MYC Asn11Ser is associated with increased risk for familial breast cancer.
    Wirtenberger M; Hemminki K; Försti A; Klaes R; Schmutzler RK; Grzybowska E; Bermejo JL; Wappenschmidt B; Bugert P; Butkiewicz D; Pamula J; Pekala W; Zientek H; Bartram CR; Burwinkel B
    Int J Cancer; 2005 Nov; 117(4):638-42. PubMed ID: 15929079
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility.
    Piccolo SR; Andrulis IL; Cohen AL; Conner T; Moos PJ; Spira AE; Buys SS; Johnson WE; Bild AH
    BMC Med Genomics; 2015 Nov; 8():72. PubMed ID: 26538066
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
    Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
    Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gene-environment interactions in breast cancer.
    Chia KS
    Novartis Found Symp; 2008; 293():143-50; discussion 150-5, 181-3. PubMed ID: 18972750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes.
    Nachmanson D; Pagadala M; Steward J; Cheung C; Bruce LK; Lee NQ; O'Keefe TJ; Lin GY; Hasteh F; Morris GP; Carter H; Harismendy O
    J Transl Med; 2022 Dec; 20(1):623. PubMed ID: 36575447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risks and Function of Breast Cancer Susceptibility Alleles.
    Torabi Dalivandan S; Plummer J; Gayther SA
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439109
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The largest genome-wide association study for breast cancer in Taiwanese Han population.
    Hsu YC; Chen HL; Cheng CF; Chattopadhyay A; Chen PS; Lin CC; Chiang HY; Liu TY; Huang CH; Kuo CC; Chuang EY; Lu TP; Tsai FJ
    Breast Cancer Res Treat; 2024 Jan; 203(2):291-306. PubMed ID: 37851288
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
    Wunderle M; Olmes G; Nabieva N; Häberle L; Jud SM; Hein A; Rauh C; Hack CC; Erber R; Ekici AB; Hoyer J; Vasileiou G; Kraus C; Reis A; Hartmann A; Schulz-Wendtland R; Lux MP; Beckmann MW; Fasching PA
    Geburtshilfe Frauenheilkd; 2018 May; 78(5):481-492. PubMed ID: 29880983
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk.
    Hughes E; Tshiaba P; Gallagher S; Wagner S; Judkins T; Roa B; Rosenthal E; Domchek S; Garber J; Lancaster J; Weitzel J; Kurian AW; Lanchbury JS; Gutin A; Robson M
    JCO Precis Oncol; 2020; 4():. PubMed ID: 32923876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of genome sequencing in personalized breast cancer prevention.
    Sieh W; Rothstein JH; McGuire V; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2322-7. PubMed ID: 25342391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.